Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Simplify your finances with user-friendly finance management tools. These resources will help you stay organized and in control of your money.
22,433 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A Mission Produce director just bought a multi-million-dollar stake in AVO. This article breaks down what insider buy...
Retirees are shifting toward stable, long-running income. This report explains why high-yielding dividend kings retir...
Could oil trend toward $60 a barrel by 2027? This article analyzes the scenario, the forces at play, and concrete sto...
Investors are watching canopy growth's medical marijuana as a potential engine for a rebound. This guide breaks down ...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
In volatile markets, pulling back can create buying opportunities. This article highlights three growth stocks to buy...
A record 207 crypto hacks were logged in H1 2026, but total losses fell to $972 million as disruption spreads beyond ...
Rocket Lab faces a watershed moment as it logs another quarter of rising revenue and a multi-billion backlog while we...
A timeless framework guides Buffett's choices: value, quality, and disciplined risk. This article breaks down Warren ...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
If Vertex pursues Crinetics, what would it mean for the stock? This article breaks down potential value, risks, and t...